Exhibit 6-3.02 - EXP.0032.0004.0043 - D. Ellis and M. Angley, ‘Guidelines for Monitoring Adverse Effects in Children and Adolescents Prescribed Antipsychotic Medication’, Women’s and Children’s Health Network You are here Home Publications Exhibit 6-3.02 - EXP.0032.0004.0043 - D. Ellis and M. Angley, ‘Guidelines for Monitoring Adverse Effects in Children and Adolescents Prescribed Antipsychotic Medication’, Women’s and Children’s Health Network Exhibit Publication date 22 September 2020 Hearing Public hearing 6: Psychotropic medication, behaviour support and behaviours of concern Download EXP.0032.0004.0043.pdf